Asensus Surgical Analyst Ratings
Asensus Surgical Hold Rating: Balancing Modest Growth and Acquisition Prospects
Asensus Surgical Analyst Ratings
HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35
Asensus Surgical Analyst Ratings
Buy Rating Affirmed on Asensus Surgical Amidst Growth and Expansion Prospects
Analysts Are Bullish on Top Healthcare Stocks: Irhythm Technologies (IRTC), Asensus Surgical (ASXC)
Analysts' Top Healthcare Picks: Asensus Surgical (ASXC), Butterfly Network (BFLY)
Cantor Downgrades Asensus to Neutral, Cites Capital Needs
Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Asensus Surgical (ASXC), Cue Health (HLTH) and Heron Therapeutics (HRTX)
Cantor Fitzgerald Reiterates Overweight on Asensus Surgical, Maintains $1 Price Target
Asensus Surgical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $2 Price Target
Asensus Surgical Analyst Ratings
Asensus Surgical (ASXC) Receives a Buy From H.C. Wainwright
H.C. Wainwright Sticks to Its Buy Rating for Asensus Surgical (ASXC)
HC Wainwright Adjusts Price Target on Asensus Surgical to $2 From $3, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Lowers Price Target to $2